Loading...
Symbols:
Loading...
Symbols:
(INFI)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on (INFI)
10 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on INFI
Most popular authors
(tracked in watchlists)
- Alan Brochstein(132)
- Mike Havrilla(103)
- Ohad Hammer(38)
- Jonathan Heller(15)
- Centient Biotech Investor(3)
Most commented on authors
- Alan Brochstein(15)
- Ohad Hammer(5)
- Centient Biotech Investor(1)
- Mike Havrilla(0)
- Jonathan Heller(0)
- Navigating the Micro-Cap Biotech Minefield
- Poniard Pharmaceuticals: Platinum Rediscovered (Part II)
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
- Biotech Stocks Day-In-Review: Amgen Rises On Speculation Over Patent Suit
- With the Discovery Partners-Infinity Pharma Deal Complete, Is It Still Worth Holding Shares
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »